News
June 4, 2007 — Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its AspirinWorks Test Kit, the Company's newest diagnostic product.
June 04, 2007
News
June 5, 2007 - GE Healthcare introduced at SNM a new version of the company’s Discovery Dimension designed to help ...
June 04, 2007News
June 5, 2007 - GVI Medical Devices, Inc., extended its nuclear cardiology line with the introduction of ClearVision ...
June 04, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
June 5, 2007 — A patch designed to help damaged cardiac tissue recover from a heart attack has been successful in early ...
June 04, 2007News
June 4, 2007 — Contrary to recent studies, proper use of a drug called aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke, according to a study in the June issue of The Journal of Thoracic and Cardiovascular Surgery.
June 03, 2007News
June 4, 2007 — A new radiological test, used to detect acute coronary trauma has the ability to save valuable time and ...
June 03, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
June 4, 2007 — Biodegradable magnesium stents have been developed to treat blockages in coronary arteries. The stents will degrade within four months and achieve the same results as conventional stents, conclude authors of an article published in this week's edition of The Lancet.
June 03, 2007News
June 1, 2007 — Abbott announced it has completed its application to the U.S. Food and Drug Administration (FDA) to seek market approval for its XIENCE V Everolimus Eluting Coronary Stent System to treat coronary artery disease, with the submission of the final module of its Pre-Market Approval (PMA) application.
May 31, 2007News
June 1, 2007 —ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, was ...
May 31, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
June 1, 2007 — Siemens recently announced the introduction of Syngo DynaCT Cardiac, which provides three-dimensional ...
May 31, 2007News
June 1, 2007 — New findings show that the majority of people untrained in how to perform cardiopulmonary resuscitation ...
May 31, 2007News
May 31, 2007 - The American Heart Association is launching a community-based program to reduce the toll of the deadliest kind of heart attack: an ST-elevation myocardial infarction (STEMI). The total blockage of a coronary artery is fatal unless treated quickly — within 30 minutes for clot-dissolving drug treatment, and within 90 minutes for angioplasty.
May 30, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
May 31 -- Cardiac Science Corp. announced today it has entered into a two-year marketing partnership with the City of ...
May 30, 2007News
May 31, 2007 — MediNotes Corporation, a leading provider of best-of-breed electronic medical record solutions for small ...
May 30, 2007News
May 30, 2007 -- Xtalks and eResearchTechnology will present a Web conference titled, "Best Practices in Cardiac Safety Data Collection Before and After the Thorough QT Trial," on June 7, 10 a.m. to noon, EDT.
May 29, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now